VEXTF (Vext Science) Beta: 0.5232 (As of Jun. 29, 2026)


VEXTF Vext Science Inc VEXTF
69 GF Score
Price $0.18
GF Value $1.06
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Vext Science Beta?

Vext Science VEXTF -3.15% 69 Beta is 0.5232 as of Jun. 29, 2026. GuruFocus rates VEXTF with a GF Score™ of 69/100 and a GF Value™ of $1.06 (Possible Value Trap). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-29), Vext Science's Beta is 0.5232.


Vext Science  (OTCPK:VEXTF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Vext Science Beta Related Terms


Vext Science Beta Historical Data

* Premium members only.

The historical data trend for Vext Science's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vext Science Beta Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 1.79 0.72 0.70 -0.27

Vext Science Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.62 -0.23 -0.27 -0.10

VEXTF vs ZTS, UTHR: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vext Science's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vext Science Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vext Science's Beta distribution charts can be found below:

* The bar in red indicates where Vext Science's Beta falls into.


VEXTF
69GF Score
Vext Science Inc VEXTF
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vext Science Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.5232 mean?
Vext Science (VEXTF) has a Beta of 0.5232 as of Jun. 29, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Vext Science and its competitors.
Is Vext Science's Beta too high?
Vext Science's current Beta is 0.5232. Overall, Vext Science has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vext Science's Beta compare to ZTS and UTHR?
Vext Science's Beta of 0.5232 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Vext Science and its competitors. Vext Science's current Beta is 0.5232. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vext Science stock overvalued right now?
Based on GuruFocus' analysis, Vext Science (VEXTF) is currently considered Possible Value Trap. The stock's GF Value™ is $1.06, compared to a current price of $0.18 — trading 83.2% below its estimated fair value. The current Beta is 0.5232. Vext Science's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Vext Science (VEXTF), the current Beta is 0.5232 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vext Science (VEXTF) Overvalued in 2026?

Based on GuruFocus' analysis, Vext Science stock appears to be undervalued. The current stock price of $0.18 is trading 83.2% below its estimated GF Value™ of $1.06. GuruFocus considers Vext Science to be Possible Value Trap.

Key valuation signals for VEXTF:

  • Beta: 0.5232
  • GF Value™: $1.06 vs. price of $0.18 (83.2% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the VEXTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vext Science Business Description

Other Exchanges VEXT:Canada
Address 4152 N. 39th Avenue, Admin, Phoenix, AZ, USA, 85019
Vext Science Inc engages in the full spectrum of the cannabis product lifecycle, from development and manufacturing to distribution. Its brands include Herbal Wellness, Appalachian Pharm, Revibe, Prism, Vapen, and Firebrand. In Arizona and Ohio, the dispensaries operate under the Herbal Wellness Center brand, while in Ohio the cultivation and manufacturing operations are licensed and branded as Appalachian Pharms Cultivation and Appalachian Pharm Processing. The Company operates through a single operating segment engaged in the cultivation, manufacturing, distribution, and sale of cannabis within the United States. All revenues are generated in the United States.
69GF Score

Get the complete analysis for VEXTF

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.18
Price
$1.06
GF Value